- Price is above Fair Value, showing premium demand versus the model.
DBV
PAR
Week ended 07 Aug 2026
Weekly Investor Report
DBV Technologies S.A. · Healthcare · Biotechnology
Latest close
2.33 EUR
-0.9%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -29.3% below the Trend Line and sits at 28.8% of its 52-week range. The latest completed week returned -0.9%, after a -18.4% four-week move. The latest news-sentiment score is 50/100.
Setup score
23
out of 100
Latest Close
2.33 EUR
7 Aug 2026
1W Return
-0.9%
latest completed week
4W Return
-18.4%
short-term follow-through
12W Return
-30.6%
quarterly tape
Trend Breadth
80.8%
42 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- Next-week expectancy is negative at 38.93% based on similar historical setup states.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.9%
Latest completed week; four-week move -18.4%.
Indicator stack
44/20
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 38.93%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
0 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -29.3% below the Trend Line and sits at 28.8% of its 52-week range. The latest completed week returned -0.9%, after a -18.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.1112-week average 0.29
12-week confirmation
Trend active2/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.11Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -18.4% over four weeks, -30.6% over 12 weeks, and 34.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year42
Trend breadth80.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.69Latest activity-pressure read.
Pressure change2.5%Four-week change in activity pressure.
Leadership-25.16Latest relative-leadership reading.
RS change-823.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 0 relevant articles.
0 positive · 0 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-48.3%Distance below the 52-week high.
13-week volatility5.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+6.8%Week of 1 May.
Worst week-15.1%Week of 5 Jun.
Latest week-0.9%Week of 7 Aug.
Shape of recent returns
Strong gains4
Modest gains6
Flat weeks0
Modest losses7
Sharp losses9
Recent vol5.7%13-week weekly-return volatility.
Base vol11.8%52-week weekly-return volatility.
Up/down split21/31Count of positive and negative weeks in the 52-week window.
Average skew10.3% / -5.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorFR Healthcare
4-week rank72 / 76
Group average0.7%
Trend breadth26.3%
Trend26.3%active weekly trend signals
MD40.8%positive activity pressure
RS19.7%positive relative leadership
Four-week leaders
IndustryFR Biotechnology
4-week rank32 / 33
Group average4.5%
Trend breadth27.3%
Trend27.3%active weekly trend signals
MD36.4%positive activity pressure
RS21.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape27/100
Trend, activity pressure, participation, and risk combine to a 27/100 tape read.
Indicator analysis21/100Latest 12-week confirmation: trend 2/12, activity pressure 0/12, relative leadership 4/12.
Activity pressure 0.11; No reversal markers Next-Week ExpectancyNegative 38.93%Next-week expectancy is negative with a 38.93% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 0 relevant articles.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 2.33 EUR | -0.9% | 3.29 EUR | 1.87 EUR | -1.69 | -25.16 | 4.2M | Off |
| 31 Jul 2026 | 2.35 EUR | -1.4% | 3.31 EUR | 1.87 EUR | -1.63 | -22.52 | 3.7M | Off |
| 24 Jul 2026 | 2.38 EUR | -8.5% | 3.34 EUR | 1.88 EUR | -1.62 | -19.85 | 5.3M | Off |
| 17 Jul 2026 | 2.60 EUR | -8.8% | 3.37 EUR | 1.88 EUR | -1.63 | -11.77 | 5.5M | Off |
| 10 Jul 2026 | 2.85 EUR | -1.5% | 3.40 EUR | 1.88 EUR | -1.73 | -2.72 | 4.1M | Off |
| 3 Jul 2026 | 2.89 EUR | 0.7% | 3.42 EUR | 1.89 EUR | -1.83 | -2.69 | 869.7K | Off |
| 26 Jun 2026 | 2.87 EUR | 1.5% | 3.39 EUR | 1.89 EUR | -1.88 | -1.39 | 670.3K | Off |
| 19 Jun 2026 | 2.83 EUR | -6.0% | 3.37 EUR | 1.89 EUR | -1.62 | -2.49 | 487.5K | Off |
| 12 Jun 2026 | 3.01 EUR | 5.7% | 3.36 EUR | 1.90 EUR | -1.57 | 5.38 | 908.4K | Off |
| 5 Jun 2026 | 2.85 EUR | -15.1% | 3.34 EUR | 1.90 EUR | -1.39 | 2.21 | 1.2M | Off |
| 29 May 2026 | 3.36 EUR | 5.6% | 3.32 EUR | 1.90 EUR | -1.16 | 22.01 | 9.0M | On |
| 22 May 2026 | 3.18 EUR | -5.1% | 3.30 EUR | 1.90 EUR | -1.27 | 17.98 | 3.3M | On |
| 15 May 2026 | 3.35 EUR | -1.5% | 3.28 EUR | 1.91 EUR | -1.17 | 28.31 | 4.0M | On |
| 8 May 2026 | 3.40 EUR | -6.2% | 3.27 EUR | 1.91 EUR | -0.98 | 29.03 | 5.5M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.